Sinemet and Zelnorm drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Sinemet (carbidopa; levodopa) and Zelnorm (tegaserod maleate). Common drug interactions include disturbance in attention among females and abdominal discomfort among males.

The phase IV clinical study analyzes what interactions people have when they take Sinemet and Zelnorm. It is created by eHealthMe based on reports of 20 people who take the same drugs from the FDA, and is updated regularly.

What is Sinemet?

Sinemet has active ingredients of carbidopa; levodopa. It is often used in parkinson's disease. eHealthMe is studying from 29,601 Sinemet users. Check the latest studies of Sinemet.

What is Zelnorm?

Zelnorm has active ingredients of tegaserod maleate. eHealthMe is studying from 7,261 Zelnorm users. Check the latest studies of Zelnorm.



On Jul, 13, 2026

20 people who take Sinemet and Zelnorm together, and have interactions are studied.

Sinemet and Zelnorm drug interactions.

What are the common drug interactions of Sinemet and Zelnorm, by gender? *:

female:

  1. Disturbance in attention
  2. Drooling (drop saliva uncontrollably from the mouth)
  3. Dysgraphia (impaired ability to learn to write)
  4. Dysphagia (a condition in which swallowing is difficult or painful)
  5. Early satiety (feeling full before completing a normal sized meal)
  6. Encephalitis (inflammation of the brain)
  7. Euphoric mood (excessively happy but may become angry or irritable)
  8. Exostosis (formation of new bone on the surface of a bone)
  9. Faecaloma (hard mass of fecal matter)
  10. Fall

male:

  1. Abdominal discomfort
  2. Asthenia (weakness)
  3. Hypotension (abnormally low blood pressure)
  4. Nausea (feeling of having an urge to vomit)
  5. Rectal haemorrhage (bleeding from anus)
  6. Renal failure chronic (long lasting kidney dysfunction)
  7. Respiratory arrest (cessation of normal respiration due to failure of the lungs to function effectively)
  8. Vomiting
  9. Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
  10. Blood chloride decreased

What are the common drug interactions of Sinemet and Zelnorm, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

  1. Back pain
  2. Bezoar (mass found trapped in the gastrointestinal system)
  3. Blindness
  4. Candidiasis (candidiasis or thrush is a fungal infection)
  5. Cerebellar syndrome (impaired blood circulation to cerebellum due to lesion in artery)
  6. Cerebrovascular accident (sudden death of some brain cells due to lack of oxygen when the blood flow to the brain is impaired by blockage or rupture)
  7. Change of bowel habit
  8. Choking (mechanical obstruction of the flow of air from the environment into the lungs)
  9. Cholelithiasis (the presence or formation of gallstones in the gallbladder or bile ducts)
  10. Colitis (inflammation of colon)

50-59:

  1. Hypotension (abnormally low blood pressure)
  2. Abdominal discomfort
  3. Asthenia (weakness)
  4. Barrett's oesophagus (barrett's oesophagus is a disorder in which the lining of the oesophagus (the tube that carries food from the throat to the stomach) is damaged by stomach acid and changed to a lining similar to that of the stomach)
  5. Circulatory collapse
  6. Diabetes mellitus inadequate control
  7. Dizziness
  8. Dyspnoea (difficult or laboured respiration)
  9. Gastritis (inflammation of stomach)
  10. Hiatus hernia (hernia resulting from the protrusion of part of the stomach through the diaphragm)

60+:

  1. Aphasia (damage to the parts of the brain that control language)
  2. Asthma
  3. Paraesthesia (sensation of tingling, tickling, prickling, pricking, or burning of a person's skin with no apparent long-term physical effect)
  4. Convulsion (muscles contract and relax rapidly and repeatedly, resulting in an uncontrolled shaking of the body)
  5. Decreased activity
  6. Delirium (wild excitement)
  7. Diabetic nephropathy (diabetic kidney disease)
  8. Diplopia (double vision)
  9. Drug ineffective
  10. Faecaloma (hard mass of fecal matter)

What are the existing conditions these people have? *

  1. Irritable Bowel Syndrome: 4 people, 20.00%
  2. Constipation: 4 people, 20.00%
  3. Diabetes: 3 people, 15.00%
  4. Diabetic Gastroparesis (paralysis of the muscles of the stomach caused by diabetes): 3 people, 15.00%
  5. Pollakiuria (abnormally frequent passage of relatively small quantities or urine): 3 people, 15.00%
  6. Pain: 3 people, 15.00%
  7. Nausea And Vomiting: 3 people, 15.00%
  8. Urinary Tract Infection: 2 people, 10.00%
  9. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 2 people, 10.00%
  10. Clostridium Difficile Colitis (inflammation of colon by clostridium difficile bacteria infection): 2 people, 10.00%

* Approximation only. Some reports may have incomplete information.

Do you take Sinemet and Zelnorm?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Sinemet and Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Sinemet:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Zelnorm:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Sinemet and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Zelnorm and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on carbidopa; levodopa and tegaserod maleate (the active ingredients of Sinemet and Zelnorm, respectively), and Sinemet and Zelnorm (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: